SCHEMBL18532606

SCHEMBL18532606

Cc1cccc(C)c1C(=O)N1CCCC(C(=O)Nc2cccc(C(C)(C)C)c2)[C@@H]1c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.41
▸ UBE2M P61081 3/20 0.41
▸ DCUN1D1 Q96GG9 3/20 0.41
▸ GAA P10253 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ PRMT5 O14744 2/20 0.39
▸ WDR77 Q9BQA1 2/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ LMNA P02545 2/20 0.38
▸ EPHX2 P34913 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12176191 1.00 ALDH1A1 (0.43) ALDH1A1CYP1A2CYP2C9RXFP1UBE2M
SCHEMBL18790105 1.00 ALDH1A1 (0.43) ALDH1A1CYP1A2CYP2C9RXFP1UBE2M
SCHEMBL12074050 1.00 ALDH1A1 (0.43) ALDH1A1CYP1A2CYP2C9RXFP1UBE2M
SCHEMBL12176383 0.95 ALDH1A1 (0.44) ALDH1A1CYP1A2CYP2C9RXFP1UBE2M
SCHEMBL18609471 0.94 HSD17B10 (0.41) ALDH1A1CYP1A2CYP2C9RXFP1UBE2M
SCHEMBL18790219 0.94 HSD17B10 (0.41) ALDH1A1CYP1A2CYP2C9RXFP1UBE2M
SCHEMBL12176122 0.94 ALDH1A1 (0.41) ALDH1A1CYP1A2CYP2C9RXFP1UBE2M
SCHEMBL12176080 0.94 HSD17B10 (0.41) ALDH1A1CYP1A2CYP2C9RXFP1UBE2M
SCHEMBL14959034 0.94 EPHX2 (0.41) ALDH1A1CYP1A2CYP2C9RXFP1UBE2M
SCHEMBL18790108 0.94 EPHX2 (0.41) ALDH1A1CYP1A2CYP2C9RXFP1UBE2M

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4015504-A1 C5AR ANTAGONISTS ChemoCentryx, Inc. (US) 2022-06-22 — — EP disclosed
EP-3508477-B1 C5AR ANTAGONISTS CHEMOCENTRYX INC (US) 2021-11-10 — — EP disclosed
EP-3508477-A1 C5AR ANTAGONISTS ChemoCentryx, Inc. (US) 2019-07-10 — — EP disclosed
US-9573897-B2 C5AR antagonists CHEMOCENTRYX, INC. (US) 2017-02-21 — — US disclosed
Send feedback